Advancing Alzheimer's

I take in quite a bit of information from multiple online sources. stem cell research and development are high on my list. one of my newsletters had an interesting release today, I'll share part of it, it's from a San Diego biotech that's my premiere pick for blockbuster potential.

Lausanne, Switzerland -March 10, 2016 - Stemedica International, SA, a Stemedica Cell Technologies, Inc. subsidiary and leader in the development of innovative stem cell-based treatments for Alzheimer's disease (AD), announced today that its Chief Scientist, Tristan Bolmont, PhD, will present at the upcoming 14th International Athens / Springfield Symposium on Advances in Alzheimer Therapy on Saturday, March 12, 2016 in Athens, Greece. This prestigious symposium draws over 1000 participants from all over the world. Leading scientists will discuss new targets and drugs for the treatment of Alzheimer's disease and novel approaches to current therapy. Dr. Bolmont's talk is titled, "Stem Cells for Alzheimer's Disease: Translation to Clinical Trials."

"I am excited to be able share the latest pre-clinical research with an eye towards clinical developments that Stemedica International has accomplished in the past year," says Dr. Bolmont. "Our uniquely-potent, hypoxically-manufactured mesenchymal stem cells significantly reduce the levels of Abeta amyloidosis in both aged and young transgenic mice along with significant reductions in neuroinflammation. Biodistribution studies show that our stem cells penetrate the blood-brain barrier. The mechanism of action research indicates that beneficial changes in Abeta and neuroinflammation may be due to increases in certain Abeta degrading enzymes and decreases in certain pro-inflammatory cytokines. Stemedica International is the first company in the United States to receive FDA approval for a Phase IIa clinical trial treating AD patients using stem cells."

so yes its early, you can't get it today but they are starting a trial in humans to see what dosing works best. this work just might help some of the old geezers out there going just a little but longer